Health2 months ago
Vanda Pharmaceuticals Hit with Downgrade Amid Mixed Analyst Ratings
Vanda Pharmaceuticals (NASDAQ:VNDA) has experienced a significant shift in its stock rating, moving from a “strong-buy” to a “hold” designation according to research conducted by Zacks...